MSB 3.21% $1.13 mesoblast limited

Ann: MSB Q2 Financial Results and Operational Highlights, page-48

  1. 647 Posts.
    lightbulb Created with Sketch. 319
    at 35 mins. regarding back pain program he says.
    currenty formulating powering for the trial.
    we expect to be working with strategic partners so we dont have plans that this would impact our opex in the short term.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.